Characterization of Growth and Osteogenic Differentiation of Rabbit Bone Marrow Stromal Cells12 1 Jason Roostaeian and Brian Carlsen contributed equally to this manuscript. 2 This work was supported by Merit Review Grant awarded to T.A.M. by U.S. Department of Veteran Affairs.

Journal of Surgical Research

Volumn 133, Issue 2, 2006, Pages 76-83

  Roostaeian, Jason ^a,b   Carlsen, Brian ^a,b   Simhaee, David ^a   Jarrahy, Reza ^a,b   Huang, Weibiao ^a,b   Ishida, Kenji ^a   Rudkin, George H ^a,b   Yamaguchi, Dean T ^a   Miller, Timothy A ^a,b  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

BMP; bone marrow stromal cells; differentiation; growth; osteogenesis; rabbit; TGF ; tissue engineering

Indexed keywords

ALKALINE PHOSPHATASE; COLLAGEN TYPE 1; OSTEOPONTIN; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; BONE MINERALIZATION; CELL COUNT; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL ISOLATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVITY; GENE EXPRESSION; GROWTH RATE; NONHUMAN; NORTHERN BLOTTING; OSTEOBLAST; PRIORITY JOURNAL; STROMA CELL;

ANIMALS; BONE MARROW CELLS; BONE MORPHOGENETIC PROTEINS; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; OSTEOGENESIS; OSTEONECTIN; OSTEOPONTIN; RABBITS; SIALOGLYCOPROTEINS; STROMAL CELLS; TISSUE ENGINEERING; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 33646786784     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2005.09.026     Document Type: Article

References (53)

1. Sommerfeldt D.W., and Rubin C.T. Biology of bone and how it orchestrates the form and function of the skeleton. Eur. Spine J. Suppl 2 (2001) S86
2. Yaszemski M.J., Oldham J.B., Lu L., and Carrier B.L. Bone Engineering. 1 (1994), Em squared, Toronto Pp. 541
3. Cancedda R., Bianchi G., Derbeis A., and Quarto R. Cell therapy for bone disease. A review of current status. Stem. Cells 21 (2003) 610
4. Spitzer R., Perka C., Limsenhayn K., and Zippel H. Matrix engineering for osteogenic differentiation of rabbit periosteal cells using alpha-tricalcium phosphate particles in a three-dimensional fibrin culture. J. Biomed. Mater. Res. 15 (2002) 690
5. Simon G.C., Khatri C.A., Wight S.A., and Wang F.W. Preliminary report on the biocompatibility of a moldable, resorbable, composite bone graft consisting of calcium phosphate cement and poly(lactide-co-glycolide) microspheres. J. Orthop. Res. 20 (2002) 473
6. Rose F.R., and Oreffo R.O. Bone tissue engineering. Hope vs hype. Biochem. Biophys. Res. Commun. 292 (2002) 1
7. Petite H., Viateau V., Bensaid W., et al. Tissue-engineered bone regeneration. Nat. Biotechnol. 18 (2000) 959
8. Gregory C.F. The current status of bone and joint transplants. Clin. Orthop 87 (1972) 165
9. Enneking W.F., and Mindell E.R. Observations on massive retrieved human allografts. J. Bone Joint Surg. 73 (1991) 1123
10. Salgado A.J., Coutinho O.P., and Reis R.L. Bone tissue engineering. State of the art and future trends. Macromol. Biosci. 4 (2004) 743
11. Heath C.A. Cells for tissue engineering. Trends Biotechnol. 18 (2000) 17
12. Derubeis A.R., and Cancedda R. Bone marrow stromal cells in bone engineering. Limitations and recent advances. Ann. Biomed. Eng. 32 (2004) 160
13. Bianco P., and Robey P.G. Stem cells in tissue engineering. Nature 414 (2001) 118
14. Bruder S.P., Kraus K.H., Goldberg V.M., and Kadiyala S. The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. J. Bone Joint Surg. Am 80 (1998) 985
15. De Bari C., Dell Accio F., Vandenabeele F., Vermeesch J.R., Raymackers J.M., and Luyten F.P. Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane. J. Cell Biol. 82 (2003) 909
16. Prockop D.J. Marrow stromal cells as stem cells for non hematopoietic tissues. Science 276 (1997) 350
17. Pittenger M.F., Mackay A.M., and Beck S.C. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143
18. Bruder S.P., Jaiswal N., and Hanesworth S.E. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J. Cell Biochem. 64 (1997) 278
19. Bianco P., Riminucci M., Gronthos S., and Robey P.G. Bone marrow stromal stem cells. Nature, biology, and potential applications. Stem. Cells 19 (2001) 180
20. Cromack D.T., Porras-Reyes B., Purdy J.A., Pierce G.F., and Mustoe T.A. Acceleration of tissue repair by transforming growth factor beta 1. Identification of in vivo mechanism of action with radiotherapy-induced specific healing deficits. Surgery 113 (1993) 36
21. Turk A., Ishida K., Jensen J.A., Wollman J., and Miller T.A. Enhanced healing of large cranial defects by an osteoinductive protein in rabbits. Plast. Reconstr. Surg. 92 (1993) 593
22. Centrella M., Horowitzm M.C., Wozney J.M., and McCarthy T.L. Transforming growth factor-β gene family members and bone. Endocrine Reviews 15 (1994) 27
23. Jadlowiec J.A., Celil A.B., and Hollinger J.O. Bone tissue engineering. Recent advances and promising therapeutic agents. Expert Opin. Biol. Ther. 3 (2003) 409
24. Isefuku S., Joyner C.J., Reed A.A.C., and Simpson A.H.R.W. Distraction osteogenesis in the Cbfa-1 +/- mouse. J. Ortho. Res. 22 (2004) 1276
25. Tang G.H., and Rabie A.B. Runx2 regulates endochondral ossification in condyle during mandibular advancement. J. Dent. Res. 84 (2005) 166
26. Gori F., Thomas T., Hicok K.C., Spelsberg T.C., and Riggs B.L. Differentiation of human marrow stromal precursor cells. Bone morphogenetic protein-2 increases OSF2/CBFA1, enhances osteoblast commitment, and inhibits late adipocyte maturation. J. Bone Miner. Res. 14 (1999) 1522
27. Gallea S., Lallemand F., Atfi A., et al. Activation of mitogen-activated protein kinase cascades is involved in regulation of bone morphogenetic protein-2-induced osteoblast differentiation in pluripotent C2C12 cells. Bone 28 (2001) 491
28. Millan F.A., Denhez F., Kondaiah P., and Akjurst R.J. Embryonic gene expression patterns of TGF beta 1, beta 2 and beta 3 suggest different developmental functions in vivo. Development 111 (1991) 131
29. Centrella M., Casinghino S., Kim J., et al. Independent changes in type I and type II receptors for transforming growth factor beta induced by bone morphogenetic protein 2 parallel expression of the osteoblast phenotype. Mol. Cell Biol. 15 (1995) 3273
30. McKinney L., and Hollinger J.O. Bone regeneration study. Transforming growth factor-beta 1 and its delivery. J. Craniofac. Surg. 7 (1996) 36
31. Govinden R., and Bhoola K.D. Genealogy, expression, and cellular function of transforming growth factor-beta. Pharmacol. Ther 98 (2003) 257
32. Chung C.Y., Iida-Klein A., Wyatt L.E., et al. Serial passage of MC3T3-E1 cells alters osteoblastic function and responsiveness to transforming growth factor-beta1 and bone morphogenetic protein-2. Biochem. Biophys. Res. Commun. 26 (1999) 246
33. Beck L.S., Amento E.P., Xu Y., et al. TGF-beta 1 induces bone closure of skull defects. Temporal dynamics of bone formation in defects exposed to rhTGF-beta 1. J. Bone Miner. Res 8 (1993) 753
34. Critchlow M.A., Bland Y.S., and Ashhurst D.E. The effect of exogenous transforming growth factor-beta 2 on healing fractures in the rabbit. Bone 16 (1995) 521
35. Nielsen H.M., Andreassen T.T., Ledet T., and Oxlund H. Local injection of TGF-β increases the strength of tibial fractures in the rat. Acta. Orthop. Scand 65 (1994) 37
36. Goldstein S.A. Tissue engineering. Functional assessment and clinical outcome. Ann. NY Acad. Sci. 961 (2002) 183
37. An Y.H., and Friedman R.J. Animal Models in Orthopedic Research. 1 (1999), CRC Press, Boca Raton
38. Huang W., Carlsen B., Wulur I., et al. BMP-2 exerts differential effects on differentiation of rabbit bone marrow stromal cells grown in two-dimensional and three-dimensional systems and is required for in vitro bone formation in a PLGA scaffold. Exp. Cell Res 299 (2004) 325
39. Ashby E.R., Rudkin G.H., Ishida K., and Miller T.A. Evaluation of a novel osteogenic factor, bone cell stimulating substance, in a rabbit cranial defect model. Plast. Reconstr. Surg. 98 (1996) 420
40. Turk A.E., Ishida K., Kobayashi M., et al. The effects of dynamic tension and reduced graft size on muscle regeneration in rabbit free muscle grafts. Plast. Reconstr. Surg. 88 (1991) 299
41. Lucarelli E., Beccheroni A., Donati D., et al. Platelet-derived growth factors enhance proliferation of human stromal stem cells. Biomaterials 24 (2003) 3095
42. Walsh S., Jefferies C., Stewart K., and Beresford J.N. TGFb1 limits the expansion of the osteoprogenitor fraction in cultures of human bone marrow stromal cells. Cell Tissue Res. 311 (2003) 187
43. Cook S.D. Preclinical and clinical evaluation of osteogenic protein-1 (BMP-7) in bony sites. Orthopedics 22 (1999) 669
44. Bruder S.P., and Fox B.S. Tissue engineering of bone. Cell based strategies. Clin. Orthop. 367 (1999) S68
45. Huang W., Rudkin G.H., Carlsen B., et al. Overexpression of BMP-2 modulates morphology, growth, and gene expression in osteoblastic cells. Exp. Cell Res. 274 (2002) 226
46. Sambrook J., Maniatis T., and Fritsch E.F. Molecular Cloning. A Laboratory Manual (1989), Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
47. Mundy G. Regulation of bone formation by bone morphogenetic proteins and other growth factors. Clin. Orthop. 324 (1996) 24
48. Gerstenfeld L.C. Osteopontin in skeletal tissue homeostasis. An emerging picture of the autocrine/paracrine functions of the extracellular matrix. J. Bone Miner. Res. 14 (1999) 850
49. Huang W., Carlsen B., Rudkin G., et al. Osteopontin is a negative regulator of proliferation and differentiation in MC3T3-E1 pre-osteoblastic cells. Bone 34 (2004) 799
50. Mackie E.J. Osteoblasts. Novel roles in orchestration of skeletal architecture. Int. J. Biochem. Cell Biol. 35 (2003) 1301
51. Aubin J.E., Liu F., Malaval L., and Gupta A.K. Osteoblast and chondroblast differentiation. Bone 17 (1995) 77S
52. Frank O., Heim M., Jakob M., et al. Real-time quantitative RT-PCR analysis of human bone marrow stromal cells during osteogenic differentiation in vitro. J. Cellular Biochem. 85 (2002) 737
53. Denhardt D.T., Noda M., O'regan A.W., Pavlin D., and Berman J.S. Osteopontin as a means to cope with environmental insults. Regulation of inflammation, tissue remodeling, and cell survival. J. Clin. Invest. 107 (2001) 1055